Diabetic retinopathy in people with Type 2 diabetes and obesity treated by Roux-en-Y gastric bypass compared with non-operated controls: with focus on the role of diabetes remission in a cross-sectional and a 6-year follow-up study.
Lene Ring MadsenT BekB RichelsenPublished in: Diabetic medicine : a journal of the British Diabetic Association (2018)
In a cross-sectional setting, individuals with Type 2 diabetes treated by RYGB showed a tendency towards less retinopathy than non-operated controls, in particular diabetes remission following RYGB was associated with less retinopathy. Moreover after 5.9 years, retinopathy in the RYGB group had progressed less than in the control group. (Clinical Trial Registry No: NCT02625649).
Keyphrases
- roux en y gastric bypass
- weight loss
- diabetic retinopathy
- glycemic control
- type diabetes
- gastric bypass
- clinical trial
- bariatric surgery
- obese patients
- cardiovascular disease
- disease activity
- optical coherence tomography
- metabolic syndrome
- insulin resistance
- ulcerative colitis
- systemic lupus erythematosus
- randomized controlled trial
- phase ii
- high fat diet induced
- skeletal muscle
- double blind
- phase iii
- body mass index